$DHR News
Last published 1w ago
- 1w agoHYFTAMDNVDADHR+1Why the Next Edge in Antibody Discovery May Be What Labs RememberGlobeNewswireAUSTIN, Texas, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Wall Street Investor News Commentary - For most of the history of antibody discovery, the hard part was producing candidates. Generative models, high-throughput assays
- 3w agoDHRDanaher Reports Third Quarter 2026 ResultsPR NewswireWASHINGTON, Oct. 21, 2026 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) today announced results for the third quarter 2026. All results in this release reflect only continuing operations and period-to-period
- 4w agoDHRDanaher Collaborates with NVIDIA to Advance Autonomous SciencePR NewswireCollaboration will bring together NVIDIA AI technologies and Danaher's scientific instruments, laboratory workflows and dataWASHINGTON, Oct. 14, 2026 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) today announced a
- 1mo agoDHRDanaher Announces Appointments of Daniel Comas and Robert Hershberg to Board of DirectorsPR NewswireWASHINGTON, Oct. 12, 2026 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) ("Danaher" or "the Company") today announced the appointment of Daniel L. Comas and Robert Hershberg, M.D., Ph.D., to the Danaher
- 1mo agoDHRJulie Sawyer Montgomery Assumes Role as Danaher President and Chief Executive OfficerPR NewswireDanaher Corporation (NYSE: DHR) ("Danaher" or "the Company") announced that, effective today, Julie Sawyer Montgomery has assumed the roles of...
- 1mo agoDHRDanaher Schedules Third Quarter 2026 Earnings Conference CallPR NewswireDanaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the third quarter 2026 on Wednesday,...
- 1mo agoDHRIntegrated DNA Technologies and Aldevron Launch New Cas9 mRNA Solutions to Accelerate Path from Gene Editing Research to DevelopmentBusiness WireCo-developed offering connects Integrated DNA Technologies’ CRISPR engineering and analysis expertise with Aldevron’s mRNA manufacturing capabilities, helping customers move from discovery toward clinical development
- 1mo agoDHRDanaher Announces Quarterly DividendPR NewswireDanaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.40 per share of its...
- 3mo agoDHRDanaher Appoints Julie Sawyer Montgomery as President and Chief Executive OfficerPR NewswireDanaher Corporation (NYSE: DHR) ("Danaher" or "the Company") announced that the Company's Board of Directors has appointed Julie Sawyer Montgomery as ...
- 3mo agoDHRDanaher Reports Second Quarter 2026 ResultsPR NewswireDanaher Corporation (NYSE: DHR) today announced results for the second quarter 2026. All results in this release reflect only continuing operations...
- 4mo agoDHRAudax Private Equity and Linden Capital Partners Agree to Sell StatLab Medical Products to Leica BiosystemsBusiness WireLinden Capital Partners ("Linden") and Audax Private Equity ("Audax"), two leading middle-market private equity firms, announced today an agreement to sell StatLab Medical Products ("StatLab" or
- 4mo agoDHRDanaher Foundation Commits $1 Million to Ebola Outbreak Relief Efforts in Central AfricaPR NewswireThe Danaher Foundation, supported by Danaher Corporation (NYSE: DHR), today announced a $1 million commitment to support urgent, on-the-ground...
- 4mo agoDHRDanaher Schedules Second Quarter 2026 Earnings Conference CallPR NewswireDanaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2026 on Tuesday, July...
- 4mo agoDHRMasimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk SoonerBusiness WirePowered by smartSET™, the Pattern Recognition Capability Analyzes Continuous Patient Data to Provide Clinicians With Earlier Insight Into Opioid-Related Respiratory Risk Masimo, a Danaher company and a specialty
- 5mo agoDHRDanaher Completes Acquisition of Masimo CorporationPR NewswireDanaher Corporation (NYSE: DHR), a global science and technology innovator, announced today that it has completed the acquisition of Masimo...
- 5mo agoDHRSPGISirius XM Holdings Set to Join S&P MidCap 400PR NewswireSirius XM Holdings Inc. (NASD: SIRI) will replace Masimo Corp. (NASD: MASI) in the S&P MidCap 400 effective prior to the opening of trading on...
- 5mo agoDHRSCIEX Launches the novus V55 System With SCIEX OS 5.0 Software and AI Enablement ToolsBusiness WireAt ASMS, SCIEX, a Danaher company and leader in life science analytical technologies, launched the novus V55 system - a next-generation triple quadrupole mass spectrometer designed for the realities of high-pressure,
- 5mo agoDHRSCIEX Advances the ZenoTOF Line With Platform-Wide Expansions in Software, Integrations, and Key CollaborationsBusiness WireAt ASMS, SCIEX, a Danaher company and leader in life science analytical technologies, introduced platform-wide advancements across its accurate mass ZenoTOF line. The updates include new SCIEX OS 5.0 software features,
- 5mo agoDHRHSICNVSTHenry Schein Announces the Election of William K. "Dan" Daniel as Independent Chairman of the BoardBusiness WireHenry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced that its Board of Directors has elected William K. "Dan" Daniel
- 6mo ago.SPX.IXICABTDHR+6Jim Cramer says today’s market is punishing stocks harder than 1999CNBCCNBC’s Jim Cramer said today’s market may resemble 1999 in some ways, but investors are punishing stocks even more aggressively.
- 6mo agoDHRDanaher to Present at Bank of America Securities Healthcare ConferencePR NewswireDanaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Bank of America...
- 6mo agoDHRDanaher Announces Quarterly DividendPR NewswireDanaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.40 per share of its...
- 6mo agoDHRMASIMasimo Shareholders Approve Acquisition by DanaherBusiness WireMasimo Corporation (NASDAQ:MASI) ("Masimo"), a leading global innovator in patient monitoring, today announced that its stockholders voted in favor of the proposal to adopt the previously announced Agreement and Plan of
- 6mo agoMDTDHRPROFDXCMWhy Medtech Giants Are Quietly Paying Up for AI DiagnosticsPR NewswireUSANewsGroup.com News Commentary – There's a quiet bidding war underway for AI diagnostics, and the price keeps climbing. The global AI in medical...
- 6mo agoDDDHRFTVGM+2CD&R Announces Jim Lico, Former Fortive CEO, as Operating AdvisorBusiness WireCD&R (or the "Firm") today announced that Jim Lico, former President and Chief Executive Officer of Fortive Corporation (NYSE:FTV), a diversified industrial growth company, has been engaged as an Operating Advisor
- 6mo agoDHRDanaher Announces Pricing of Euro-Denominated Senior Notes OfferingPR NewswireDanaher Corporation (NYSE: DHR) ("Danaher") announced today that it has priced an offering of the following euro-denominated senior notes (the...
- 6mo agoDHRDanaher Reports First Quarter 2026 ResultsPR NewswireDanaher Corporation (NYSE: DHR) today announced results for the first quarter 2026. All results in this release reflect only continuing operations...
- 7mo agoDHRBeckman Coulter Diagnostics Earns CE Mark for New Assay Delivering Bacterial vs. Viral Infection Results in Approximately 20 MinutesPR NewswireBeckman Coulter Diagnostics, a Danaher company and global leader in clinical diagnostics, today announced it has received CE 2797 mark under IVDR for ...
- 7mo agoDHREMROTLCROK+1AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost AdvantagesGlobeNewswireAUSTIN, Texas, April 09, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: As regulatory demands intensify and production environments become more complex, pharmaceutical manufacturers are shifting beyond
- 7mo agoDHRDanaher Schedules First Quarter 2026 Earnings Conference CallPR NewswireDanaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2026 on Tuesday, April...
- 8mo agoDHRDanaher Announces Quarterly DividendPR NewswireDanaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.40 per share of its...
- 8mo agoDHRDanaher to Present at TD Cowen Health Care ConferencePR NewswireDanaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the TD Cowen Healthcare...
- 8mo agoDHRMASIMasimo to be Acquired by Danaher for $180.00 Per ShareBusiness WireMasimo Corporation (NASDAQ:MASI) ("Masimo"), a leading global medical innovator, today announced that it has entered into a definitive agreement pursuant to which Danaher Corporation (NYSE:DHR) ("Danaher") will acquire
- 8mo agoDHRDanaher To Acquire Masimo CorporationPR NewswireDanaher Corporation (NYSE: DHR), a global science and technology innovator, announced today that it has entered into a definitive agreement to...
- 9mo agoDHRDanaher Reports Fourth Quarter and Full Year 2025 ResultsPR NewswireDanaher Corporation (NYSE: DHR) (the "Company") today announced results for the fourth quarter and full year 2025. All results in this release...
- 9mo agoNUEBAGMGLW+7Cramer’s week ahead: Earnings from Meta, Microsoft and Apple. Plus, a Fed meetingCNBCCramer on Friday also named which stocks investors should consider buying after earnings.
- 10mo agoDHRDanaher CEO to Comment on Financial PerformancePR NewswireDanaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Rainer M. Blair, will comment tomorrow on...
- 10mo agoDHRDanaher to Present at J.P. Morgan Healthcare ConferencePR NewswireDanaher Corporation (NYSE: DHR) announced that its President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P. Morgan...
- 10mo agoDHRDanaher Schedules Fourth Quarter 2025 Earnings Conference CallPR NewswireDanaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2025 on Wednesday,...
- 11mo agoDHRDanaher Announces Quarterly DividendPR NewswireDanaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its...
- 1y agoDHRDanaher to Present at Jefferies Global Healthcare ConferencePR NewswireDanaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Jefferies Global...
- 1y agoAVTRDHRFIVEHUMNotice to Long-Term Shareholders of Avantor, Inc. (NYSE: AVTR); Danaher Corporation (NYSE: DHR); Five Below, Inc. (NASDAQ: FIVE); and Humana Inc. (NYSE: HUM): Grabar Law Office Investigates Claims on Your BehalfGlobeNewswirePHILADELPHIA, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Avantor, Inc. (NYSE:AVTR): Grabar Law Office is investigating claims on behalf of shareholders of Avantor, Inc. (NYSE:AVTR). The investigation concerns whether certain
- 1y agoDHRDanaher Reports Third Quarter 2025 ResultsPR NewswireDanaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended September 26, 2025. Key Third Quarter 2025 Results Net...
- 1y agoDHRDanaher Schedules Third Quarter 2025 Earnings Conference CallPR NewswireDanaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the third quarter 2025 on Tuesday, October...
- 1y agoDHRBeckman Coulter Diagnostics Launches Industry First Fully Automated, High Throughput BD-Tau Research Use Only Immunoassay Test, Advancing Neurodegenerative Clinical ResearchPR NewswireBeckman Coulter Diagnostics, a Danaher company and a leader in global clinical diagnostics innovation, today launched the industry's first fully...
- 1y agoDHRDanaher Announces Quarterly DividendPR NewswireDanaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its...
- 1y agoALOTDHRVLTOZBRAAstroNova Appoints Jorik E. Ittmann as President and Chief Executive OfficerBusiness WireLeverages Mr. Ittmann's extensive print industry and international business experience Padraig Finn, with over 16 years in the print industry, promoted to Senior Vice President, Product Identification Tom Carll,
- 1y agoDHRDanaher Appoints Jonathan Leiken as General CounselPR NewswireDanaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Jonathan Leiken has been appointed...
- 1y agoDHRDanaher Announces Transition Plan for Chief Financial OfficerPR NewswireDanaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Matthew Gugino, currently Group Chief ...
- 1y agoDHRDanaher Reports Second Quarter 2025 ResultsPR NewswireDanaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended June 27, 2025. Key Second Quarter 2025 Results Net...